跳至主要内容
临床试验/NCT01202461
NCT01202461已完成1 期

Three-year Result of Triple Therapy of Vitrectomy, Intravitreal Triamcinolone and Macular Laser Photocoagulation for Intractable Diabetic Macular Edema

Samsung Medical Center2 个研究点 分布在 2 个国家目标入组 41 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
41
试验地点
2
主要终点
Best-corrected visual acuity

研究概览

简要总结

This study is designed to report 3-year result of triple therapy of vitrectomy, intravitreal triamcinolone and macular laser photocoagulation for intractable diabetic macular edema.

Previously author reported 1-year result(Am J Ophthalmol. 2007 Dec;144(6):878-885. Epub 2007 Oct 15.).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinical diagnosis of diabetes mellitus
  • intractable diffuse DME (diffuse DME which did not respond to or recurred after the previous IVTA and/or macular focal laser photocoagulation)
  • central subfield macular thickness (CST) greater than 250μm

排除标准

  • presence of vitreomacular traction
  • a prior history of treatment for the DME within 3 months or vitreoretinal surgery

结局指标

主要结局

Best-corrected visual acuity

时间窗: At baseline, 6,12,24,36 months after surgery

Measurement of visual acuity at every visit. VA at every visit was compared from VA at baseline

次要结局

  • Central subfield macular thickness(0,6,12,24,36 months after surgery)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验